Drug intelligence / Profile preview

Qingjie Jie Re

Development stage: Unknown
Lead developer: Children's Hospital of Fudan University
Administration: Oral

Overview

Qingjie Jie Re is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Children's Hospital of Fudan University. Formulated as a granule, it is primarily used in pediatric medicine for the treatment of influenza and upper respiratory tract infections. The preparation is designed to clear heat, detoxify, and provide antipyretic (fever-reducing) effects. Clinical research, including the trial ChiCTR2200057418, has focused on observing its therapeutic efficacy and safety in children with influenza. As a hospital-made preparation (院内制剂), it is typically produced and dispensed within the pharmacy department of the developing institution.

Other names: Qingjie Jie Re granuleQingjie Jiere granule清解解热颗粒

Beyond the preview

Go deeper on Qingjie Jie Re.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingjie Jie Re.

Explore the full profile